Distribution of microRNA profiles in pre-clinical and clinical forms of murine and human prion disease

[1]  K. Z. Masoodi,et al.  Database for annotation, visualisation and integrated discovery , 2022, Bioinformatics for Everyone.

[2]  A. Bizzi,et al.  Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging. , 2020, JAMA neurology.

[3]  L. Sacchetto,et al.  High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD , 2020, International journal of molecular sciences.

[4]  J. Schott,et al.  A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis , 2020, Nature Communications.

[5]  C. Masters,et al.  Small RNA fingerprinting of Alzheimer’s disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles , 2020, Journal of extracellular vesicles.

[6]  C. Soto,et al.  Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting disease , 2019, Scientific Reports.

[7]  Veronika A. Herzog,et al.  Time-Resolved Small RNA Sequencing Unravels the Molecular Principles of MicroRNA Homeostasis. , 2019, Molecular cell.

[8]  I. Ferrer,et al.  Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease , 2019, Journal of Clinical Neuroscience.

[9]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[10]  J. Díez,et al.  Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis , 2018, PLoS pathogens.

[11]  C. Duyckaerts,et al.  Accuracy of diagnosis criteria in patients with suspected diagnosis of sporadic Creutzfeldt-Jakob disease and detection of 14-3-3 protein, France, 1992 to 2009 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  K. Blennow,et al.  Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease , 2016, Scientific Reports.

[13]  Jing Wang,et al.  MiRNA expression profiles in the brains of mice infected with scrapie agents 139A, ME7 and S15 , 2016, Emerging microbes & infections.

[14]  K. Mimori,et al.  Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer , 2015, British Journal of Cancer.

[15]  C. Rowe,et al.  Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment , 2014, Molecular Psychiatry.

[16]  Muneesh Tewari,et al.  Quantitative and stoichiometric analysis of the microRNA content of exosomes , 2014, Proceedings of the National Academy of Sciences.

[17]  Lesley Cheng,et al.  Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. , 2014, Kidney International.

[18]  S. Arora,et al.  Hemolyzed Samples Should be Processed for Coagulation Studies: The Study of Hemolysis Effects on Coagulation Parameters , 2014, Annals of medical and health sciences research.

[19]  Lesley Cheng,et al.  Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.

[20]  A. Karch,et al.  Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia , 2013, PloS one.

[21]  A. Haqqani,et al.  Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells , 2013, Fluids and Barriers of the CNS.

[22]  S. Booth,et al.  Early Mechanisms of Pathobiology Are Revealed by Transcriptional Temporal Dynamics in Hippocampal CA1 Neurons of Prion Infected Mice , 2012, PLoS pathogens.

[23]  P. V. van Rijen,et al.  MicroRNA-146a: A Key Regulator of Astrocyte-Mediated Inflammatory Response , 2012, PloS one.

[24]  A. Hill,et al.  Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells , 2012, Nucleic acids research.

[25]  Hamid Cheshmi.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .

[26]  C. Théry.  Exosomes: secreted vesicles and intercellular communications , 2011, F1000 biology reports.

[27]  M. Rowan,et al.  Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites , 2011, Nature communications.

[28]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[29]  S. Spijker,et al.  Dissection of Rodent Brain Regions , 2011 .

[30]  A. Hill,et al.  The brain to gut pathway: a possible route of prion transmission , 2010, Gut.

[31]  George Perry.  Faculty Opinions recommendation of The prion protein as a receptor for amyloid-beta. , 2010 .

[32]  C. Tabin,et al.  miRNA malfunction causes spinal motor neuron disease , 2010, Proceedings of the National Academy of Sciences.

[33]  K. Sonntag,et al.  MicroRNAs and deregulated gene expression networks in neurodegeneration , 2010, Brain Research.

[34]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[35]  M. Kiebler,et al.  Faculty Opinions recommendation of Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. , 2009 .

[36]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[37]  Benjamin Haibe-Kains,et al.  microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. , 2009, Blood.

[38]  I. Plante,et al.  MicroRNA-298 and MicroRNA-328 Regulate Expression of Mouse β-Amyloid Precursor Protein-converting Enzyme 1* , 2009, Journal of Biological Chemistry.

[39]  Stephen P Finn,et al.  Potential role of miR-9 and miR-223 in recurrent ovarian cancer , 2008, Molecular Cancer.

[40]  Sarah Medina,et al.  Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes , 2008, BMC Genomics.

[41]  B. Steinhoff,et al.  Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. , 2007, Brain : a journal of neurology.

[42]  C. Masters,et al.  Correlative studies support lipid peroxidation is linked to PrPres propagation as an early primary pathogenic event in prion disease , 2006, Brain Research Bulletin.

[43]  R. Linden,et al.  Interaction of Cellular Prion and Stress-Inducible Protein 1 Promotes Neuritogenesis and Neuroprotection by Distinct Signaling Pathways , 2005, The Journal of Neuroscience.

[44]  R. Somerville,et al.  Microdissection: A method developed to investigate mechanisms involved in transmissible spongiform encephalopathy pathogenesis , 2004, BMC infectious diseases.

[45]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[46]  Shu G. Chen,et al.  Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.

[47]  R. Linden,et al.  Cellular prion protein transduces neuroprotective signals , 2002, The EMBO journal.

[48]  J. Collinge.  Their Causes and Molecular Basis , 2001 .

[49]  J. Collinge.  Prion diseases of humans and animals: their causes and molecular basis. , 2001, Annual review of neuroscience.

[50]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[51]  M. Palmer,et al.  Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease , 1991, The Lancet.

[52]  M. Ohta,et al.  Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents , 1979, Annals of neurology.